Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study

BMC Medical Research Methodology201414:66

DOI: 10.1186/1471-2288-14-66

Received: 8 November 2013

Accepted: 6 May 2014

Published: 15 May 2014

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
8 Nov 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
11 Nov 2013 Author responded Author comments - Nicole Pratt
Resubmission - Version 3
11 Nov 2013 Submitted Manuscript version 3
29 Nov 2013 Reviewed Reviewer Report - Koen B. Pouwels
9 Dec 2013 Reviewed Reviewer Report - Jesper Hallas
11 Dec 2013 Reviewed Reviewer Report - Scott Garrison
12 Apr 2014 Author responded Author comments - Nicole Pratt
Resubmission - Version 4
12 Apr 2014 Submitted Manuscript version 4
6 May 2014 Author responded Author comments - Nicole Pratt
Resubmission - Version 5
6 May 2014 Submitted Manuscript version 5
Publishing
6 May 2014 Editorially accepted
15 May 2014 Article published 10.1186/1471-2288-14-66

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia
(2)
Department of Health and Ageing, Pharmaceutical Evaluation - DUSC/ESC Section, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division

Advertisement